GPX4 and diabetes mellitus: In diabetes, upregulated MAP4K4 dramatically interferes with mitochondrial morphology and function, inhibits GPX4 expression, and promotes endothelial ferroptosis by stimulating SNO-Drp1, ultimately promoting cardiac microvascular injury.